NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Annual out-of-pocket treatment costs for multiple sclerosis increased by 125% from 2002 to 2021 in the US, driven mainly by ...

We know so much more about multiple sclerosis (MS) than we used to. But one important theme is that we’ve become much better at treating the relapsing form of this disease and changing its natural ...

A new study has discovered a possible biomarker linked to multiple sclerosis disease progression that could help identify ...

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

New research suggests that balance and coordination problems in multiple sclerosis may begin when key brain cells slowly run ...

People with multiple sclerosis (pwMS) face a lifelong, slowly progressive disease that remains incurable despite new therapies. A key part of helping pwMS and their families or support group to ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...